Similar Articles
1231 Hepatocellular carcinoma: Where are we?
1232 Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
1233 Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
1234 Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art
1235 Hepatocellular carcinoma and hepatitis B surface protein
1236 Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation
1237 Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
1238 Liver transplantation in acute liver failure: A challenging scenario
1239 Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment
1240 Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA